Pharma innovators have long pursued a variety of deal structures to navigate the risks associated with the drug development process. Here we explore the legal and regulatory dynamics of these creative ...
This is the fourth article in our “Strategies for Winning Deals” series, which highlights ways that private equity sponsors can gain a competitive edge in buyouts without overpaying In today’s ...
Commercial Property Assessed Clean Energy (C-PACE) is evolving. Driven by growing deal sizes and innovative structuring, C-PACE is emerging as a foundational, primary source of funding for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results